Prospects of Neutralizing Nanobodies Against SARS-CoV-2.

Frontiers in Immunology
Fangfang ChenFan Jiang

Abstract

Since December 2019, the SARS-CoV-2 has erupted on a large scale worldwide and spread rapidly. Passive immunization of antibody-related molecules provides opportunities for prevention and treatment of high-risk patients and children. Nanobodies (Nbs) have many strong physical and chemical properties. They can be atomized, administered by inhalation, and can be directly applied to the infected site, with fast onset, high local drug concentration/high bioavailability, and high patient compliance (no needles). It has very attractive potential in the treatment of respiratory viruses. Rapid and low-cost development of Nbs targeting SARS-CoV-2 can quickly be achieved. Nbs against SARS-CoV-2 mutant strains also can be utilized quickly to prevent the virus from escaping. It provides important technical supports for the treatment of the SARS-CoV-2 and has the potential to become an essential medicine in the toolbox against the SARS-CoV-2.

References

May 5, 1998·Molecular Immunology·K B VuS Muyldermans
Apr 21, 1999·Biochimica Et Biophysica Acta·R H van der LindenC T Verrips
Oct 30, 2001·Advances in Immunology·V K NguyenS Muyldermans
Feb 16, 2002·Protein Science : a Publication of the Protein Society·Mireille DumoulinAndre Matagne
Dec 30, 2006·Nature Reviews. Drug Discovery·John S Patton, Peter R Byron
Nov 6, 2009·The Journal of General Virology·Benedikte SerruysPeter Vanlandschoot
Jun 23, 2010·Antiviral Research·Bert ThysBart Rombaut
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven JähnichenMartine J Smit
Apr 1, 2011·The Journal of Infectious Diseases·Lorena Itatí IbañezXavier Saelens
Sep 24, 2011·Antiviral Research·Peter VanlandschootXavier Saelens
Apr 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander W TarrThomas Krey
Apr 5, 2014·Trends in Biotechnology·Thomas De MeyerAnn Depicker
Jan 24, 2015·Current Opinion in Structural Biology·Aline DesmyterChristian Cambillau
Sep 8, 2016·PloS One·Lucía MaffeyViviana Parreño
Mar 21, 2017·Analytical Chemistry·Virginia J Bruce, Brian R McNaughton
Apr 7, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Yuelong Shu, John McCauley
Sep 28, 2017·Nature·Aaron ChevalierDavid Baker
Nov 28, 2017·Applied Microbiology and Biotechnology·Yongkang Liu, He Huang
Feb 13, 2018·Nature Structural & Molecular Biology·Conor McMahonAndrew C Kruse
Feb 27, 2018·Molecular Immunology·Wenshuai LiuDongxiao Feng
Apr 28, 2018·PLoS Computational Biology·Jared Adolf-BryfogleRoland L Dunbrack
May 23, 2018·Scientific Reports·Patrick KunzJörg D Hoheisel
Aug 14, 2018·Science Advances·V Stalin RajBart L Haagmans
Oct 10, 2018·Chemical Society Reviews·Pietro SormanniMichele Vendruscolo
Feb 9, 2019·Analytical and Bioanalytical Chemistry·J-Pablo SalvadorM-Pilar Marco
Apr 3, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yushu Joy XieHidde Ploegh
Jul 20, 2019·Human Antibodies·Manzoor A MirSyed Suhail Hamdani
Nov 7, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ivana Jovčevska, Serge Muyldermans
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Apr 15, 2020·Protein Expression and Purification·Ario de Marco
Apr 23, 2020·Nature Reviews. Immunology·Akiko Iwasaki, Yexin Yang
May 16, 2020·Cell Host & Microbe·Yanling WuTianlei Ying

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Rosetta
AlphaFold

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.